Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma
Titel:
Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma
Auteur:
Auel, Britta Goldschmidt, Hartmut Geer, Thomas Moehler, Thomas M. Platzbecker, Uwe Naumann, Ralph Blau, Igor Hänel, Mathias Knauf, Wolfgang Nückel, Holger Salwender, Hans-Jürgen Scheid, Christof Weisel, Katja Gorschlüter, Marcus Glasmacher, Axel Schmidt-Wolf, Ingo G. H.
Verschenen in:
Indian journal of hematology and blood transfusion